A detailed history of Smead Capital Management, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Smead Capital Management, Inc. holds 3,380,469 shares of MRK stock, worth $331 Million. This represents 5.63% of its overall portfolio holdings.

Number of Shares
3,380,469
Previous 2,958,823 14.25%
Holding current value
$331 Million
Previous $366 Million 4.8%
% of portfolio
5.63%
Previous 5.87%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$111.15 - $128.97 $46.9 Million - $54.4 Million
421,646 Added 14.25%
3,380,469 $384 Million
Q2 2024

Aug 09, 2024

SELL
$123.8 - $132.96 $10.9 Million - $11.7 Million
-88,152 Reduced 2.89%
2,958,823 $366 Million
Q1 2024

May 10, 2024

BUY
$113.24 - $131.95 $14.1 Million - $16.4 Million
124,503 Added 4.26%
3,046,975 $402 Million
Q4 2023

Jan 31, 2024

BUY
$100.18 - $109.02 $1.16 Million - $1.26 Million
11,572 Added 0.4%
2,922,472 $319 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $10.3 Million - $11.4 Million
-99,873 Reduced 3.32%
2,910,900 $300 Million
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $4.02 Million - $4.38 Million
-37,019 Reduced 1.21%
3,010,773 $347 Million
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $7.12 Million - $7.95 Million
69,193 Added 2.32%
3,047,792 $324 Million
Q4 2022

Feb 10, 2023

BUY
$87.44 - $112.11 $22.3 Million - $28.6 Million
255,497 Added 9.38%
2,978,599 $330 Million
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $3.65 Million - $4.1 Million
43,226 Added 1.61%
2,723,102 $235 Million
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $13.1 Million - $14.9 Million
157,342 Added 6.24%
2,679,876 $244 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $28.7 Million - $32.2 Million
391,023 Added 18.34%
2,522,534 $207 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $28.7 Million - $36 Million
397,372 Added 22.91%
2,131,511 $163 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $2.78 Million - $3.06 Million
38,828 Added 2.29%
1,734,139 $130 Million
Q2 2021

Jul 30, 2021

BUY
$70.31 - $77.77 $14.6 Million - $16.1 Million
207,316 Added 13.93%
1,695,311 $132 Million
Q1 2021

May 04, 2021

BUY
$68.86 - $81.11 $54 Million - $63.7 Million
784,822 Added 111.61%
1,487,995 $115 Million
Q4 2020

Feb 03, 2021

SELL
$71.77 - $79.65 $2.27 Million - $2.52 Million
-31,624 Reduced 4.3%
703,173 $57.5 Million
Q3 2020

Nov 04, 2020

SELL
$73.18 - $82.95 $5.65 Million - $6.41 Million
-77,238 Reduced 9.51%
734,797 $61 Million
Q2 2020

Aug 10, 2020

SELL
$70.42 - $80.13 $4.88 Million - $5.55 Million
-69,272 Reduced 7.86%
812,035 $62.8 Million
Q1 2020

Apr 30, 2020

SELL
$63.36 - $87.82 $2.79 Million - $3.87 Million
-44,098 Reduced 4.77%
881,307 $67.8 Million
Q4 2019

Jan 30, 2020

BUY
$77.58 - $87.54 $954,078 - $1.08 Million
12,298 Added 1.35%
925,405 $84.2 Million
Q3 2019

Oct 25, 2019

SELL
$76.08 - $82.93 $1.99 Million - $2.17 Million
-26,217 Reduced 2.79%
913,107 $76.9 Million
Q2 2019

Jul 26, 2019

SELL
$69.84 - $81.59 $1.65 Million - $1.93 Million
-23,697 Reduced 2.46%
939,324 $78.8 Million
Q1 2019

May 09, 2019

SELL
$69.58 - $79.36 $1.74 Million - $1.98 Million
-24,965 Reduced 2.53%
963,021 $80.1 Million
Q4 2018

Feb 04, 2019

SELL
$65.24 - $75.71 $2.64 Million - $3.06 Million
-40,399 Reduced 3.93%
987,986 $75.5 Million
Q3 2018

Oct 23, 2018

SELL
$57.69 - $67.84 $1.59 Million - $1.87 Million
-27,597 Reduced 2.61%
1,028,385 $73 Million
Q2 2018

Jul 24, 2018

SELL
$50.83 - $59.72 $997,233 - $1.17 Million
-19,619 Reduced 1.82%
1,055,982 $64.1 Million
Q1 2018

May 04, 2018

SELL
$50.96 - $59.23 $33,939 - $39,447
-666 Reduced 0.06%
1,075,601 $58.6 Million
Q4 2017

Feb 13, 2018

SELL
$51.62 - $61.64 $2.62 Million - $3.13 Million
-50,731 Reduced 4.5%
1,076,267 $60.6 Million
Q3 2017

Nov 06, 2017

BUY
$58.67 - $63.13 $66.1 Million - $71.1 Million
1,126,998
1,126,998 $72.2 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Smead Capital Management, Inc. Portfolio

Follow Smead Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smead Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Smead Capital Management, Inc. with notifications on news.